A dietary supplement containing Berberine and titrated extracts of Reishi and Fenugreek useful for controlling blood levels of cholesterol.
With patented Lacursome® technology that improves intestinal absorption of Berberine.
Remorex was tested in an observational study in patients with mild hypercholesterolemia for six months and was effective in significantly reducing levels of total cholesterol (-21%), LDL (-31%), and triglycerides (-17%), slightly increasing HDL cholesterol levels (+9%), and reducing inflammation as indicated by C-reactive protein levels (-28%).
In addition, it was tested in patients with moderate hypercholesterolemia who do not respond appropriately to statin therapy, for six months. Remorex add-on restores a physiological situation by significantly reducing total cholesterol (-29%), LDL (-40%) and triglycerides (-26%), increasing HDL cholesterol levels (+8%) and reducing C-reactive protein (-54%). The add-on of Remorex to drug therapy makes it possible to keep the dose of statin constant while avoiding possible side effects associated with higher doses.
With patented Lacursome® technology that increases the absorption and improves the bioavailability of Berberine, which is known to be poorly absorbed in the intestine due to the molecule’s high hydrophobicity and the presence of P-gp pumps responsible for its efflux into the intestinal lumen.
Read the clinical study on Remorex
| Nutrition information | Per maximum daily dose (1 tablet) |
| Berberis ES tit. 85% of which berberine |
590 mg 500 mg |
| Reishi ES tit. 10% of which polysaccharides |
200 mg 20 mg |
| Fenugreek ES tit. 50% of which saponins |
150 mg 75 mg |
Berberis (Berberis aristata DC.) root ES tit. 85% berberine; Reishi (Ganoderma lucidum (Curtis) P. Karst.) fungal fruiting body ES tit. 10% polysaccharides; Fenugreek (Trigonella foenum-graecum L.) seed ES tit. 50% saponins; Bulking agents: Hydroxypropylcellulose, Microcrystalline cellulose; Cocoa butter; Anti-caking agents: Silicon dioxide, Magnesium salts of fatty acids.
30 tablets.
Hypercholesterolemia is a condition characterized byelevated total and/or LDL cholesterol concentration in the blood. In many cases, it is clinically silent, but can manifest with indirect signs, systemic complications, and significant psychological consequences. Hypercholesterolemia, in the absence of complications, is asymptomatic in most cases.
Hypercholesterolemia is a causal risk factor for atherosclerotic disease. Symptoms then result from its complications, which can be very serious: myocardial infarction, peripheral arterial disease, ischemic stroke. These symptoms are not directly attributable to hypercholesterolemia, but to the progression of the atherosclerotic lesion promoted by it.
Although often asymptomatic, the diagnosis of hypercholesterolemia can result in a nonnegligible mental burden, especially in young or high-risk family patients. The psychological aspects most frequently encountered arelatent disease anxiety, that is, the awareness of being affected by a "silent but dangerous" condition, which can generate distress and hypervigilance; worry about heart attack or future cardiovascular events, even in the absence of symptoms; and guilt related to diet or lifestyle, especially in individuals with difficulty changing habits.
An increased mental burden relatively to this issue could result in reduced adherence to therapy, somatization of nonspecific symptoms, and more generally a strong impact on quality of life and perceived well-being.
Living with dyslipidemia means learning to live with a silent but present condition that acts below the surface, but profoundly affects the perception of one's health status. An intimate, personal experience that demands listening and respect in its complexity.
Remorex was formulated to start treating hypercholesterolemia at an early stage, to avoid the risk of complications, and to support and supplement traditional drug treatment, to provide a solution that makes you freer and lighter.
Hypercholesterolemia often develops as a consequence of a combination of physiological, behavioral, and systemic factors that, over time, alter the body's lipid balance. This is not a sudden event, but a gradual process in which the accumulation of small dysfunctions leads to a steady change in blood parameters, potentially impacting cardiovascular risk. Underlying this is inefficient regulation of cholesterol metabolism, which may result from increased hepatic synthesis, reduced low-density lipoprotein removal capacity, or altered expression of specific receptors.
In the modern context, adiet excessively rich in saturated fats, refined sugars, and ultra-processed foods promotes the progressive increase of LDL cholesterol, adversely affecting the balance between the different lipid fractions. Sedentary lifestyle is also a relevant predisposing factor, as it limits the activation of metabolic processes responsible for mobilization and utilization of lipids as an energy source. The result is a tendency to accumulation, which may manifest initially in a subclinical form but, over time, contributes to increased cardiovascular risk.
Another element to consider is the role of chronic low-grade inflammation and oxidative stress. These conditions, often linked to disordered lifestyles or environmental factors, promote the modification of LDL cholesterol into forms more susceptible to oxidation, a key event in the process of endothelial dysfunction and the progression of vascular damage. Chronic emotional stress can also have a significant impact, altering the hypothalamic-pituitary-adrenal axis and affecting lipid metabolism through neuroendocrine mechanisms.
Finally, a genetic component may contribute to making some people more prone to develop hypercholesterolemia even in the presence of a relatively balanced lifestyle. In these cases, controlling lipid levels requires constant attention and conscious management geared toward maintaining long-term cardiovascular health. Understanding these dynamics means recognizing that the lipid profile is the result of a complex network of interactions, in which each element contributes to determine a balance that must be preserved with care and awareness.
Remorex is a dietary supplement developed to intervene physiologically and synergistically in the control of the lipid profile, through an innovative formulation that takes advantage of the combination of natural active ingredients and the exclusive Lacursome® technology. The heart of Remorex's hypolipidemic action lies in the presence of berberine, a plant alkaloid known for its ability to modulate lipid and glucose metabolism. This substance, delivered through lipid nanoparticles derived from cocoa butter, is more efficiently absorbed through Lacursome® technology, which enhances its bioavailability and clinical efficacy.
The supplementation of berberine with Reishi and Fenugreek extracts allows the product's spectrum of action to be broadened, offering targeted support for both the reduction of LDL cholesterol and the possible increase in HDL cholesterol. Berberine acts on two different levels of cholesterol metabolism: reduction of endogenous synthesis through changes in the activity of the key enzyme for this process, and increase in the reuptake of cholesterol from the blood by stimulating the expression of receptors involved in this mechanism and repressing their degradation.
Reishi, a mushroom traditionally used in Oriental medicine, is recognized for its adaptogenic and liver activity-regulating properties, contributing to the maintenance of lipid balance through mechanisms that modulate cholesterol absorption at the intestinal level and its excretion at the hepatic level.
Fenugreek, rich in saponins and soluble fiber, acts synergistically with berberine at the receptor level, further promoting fat metabolism and participating in the normalization of blood parameters related to cardiovascular health.
The mechanism of action of Remorex unfolds on several levels: on the one hand, it acts directly on hepatic cholesterol synthesis, modulating the biosynthetic pathways responsible for lipid accumulation; on the other hand, it supports the physiological disposal of low-density lipoproteins, contributing to better management of blood levels. The hypolipidemic action is accompanied by a systemic rebalancing effect on the entire metabolism, with perceptible benefits in terms of stability, continuity, and overall well-being.
The dietary supplementation proposed by Remorex is designed for those seeking an approach that respects physiology, but at the same time is technologically advanced. The choice to use active ingredients of natural origin, associated with a patented technology such as Lacursome®, guarantees a highly effective formulation, ideal for accompanying cholesterol rebalancing pathways with a tolerable and safe profile, without side effects. Remorex thus represents a premium solution, in line with the needs of those who wish to take conscious and targeted action in the management of their lipid and cardiovascular well-being.
Attivo dal lunedì a venerdì dalle 9 alle 18
Compila il modulo di contatto online
Ti risponderemo entro 24/48 ore lavorative
